Risk-benefit profile of intensive blood pressure treatment

Lancet Diabetes Endocrinol. 2018 Aug;6(8):601-602. doi: 10.1016/S2213-8587(18)30175-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents
  • Blood Pressure / drug effects
  • Diabetes Mellitus*
  • Humans
  • Renal Insufficiency, Chronic*

Substances

  • Antihypertensive Agents